
EVESOR, a model-based, multiparameter, Phase I trial to optimize the benefit/toxicity ratio of everolimus and sorafenib
El-Madani, Mévidette, Colomban, Olivier, Tod, Michel, Maillet, Denis, Peron, Julien, Rodriguez-Lafrasse, Claire, Badary, Osama A, Valette, Pierre-Jean, Lefort, Thibaud, Cassier, Philippe, El-Shenawy,Volume:
13
Langue:
english
Journal:
Future Oncology
DOI:
10.2217/fon-2016-0357
Date:
April, 2017
Fichier:
PDF, 1.53 MB
english, 2017